Evidence map›Paper›PMID 27343298›Full record

ArticleJournal of clinical microbiology2016

Correction for Six et al., Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections.

Anne Six, Arnaud Firon, Céline Plainvert, Camille Caplain, Abdelouhab Bouaboud, Gérald Touak, Nicolas Dmytruk, Magalie Longo, Franck Letourneur, Agnès Fouet and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Anne SixINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Arnaud FironInstitut Pasteur, Unité Biologie des Bactéries Pathogènes à Gram Positif, Paris, France.
Céline PlainvertINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Camille CaplainINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Abdelouhab BouaboudINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Gérald TouakCentre National de Référence des Streptocoques, Paris, France.
Nicolas DmytrukCentre National de Référence des Streptocoques, Paris, France.
Magalie LongoINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Franck LetourneurINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Agnès FouetINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.
Patrick Trieu-CuotInstitut Pasteur, Unité Biologie des Bactéries Pathogènes à Gram Positif, Paris, France.
Claire PoyartINSERM U 1016, Institut Cochin, Team Barriers and Pathogens, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27343298
PMCPMC4922104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.